Be Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BE PHARMS, and what generic and branded alternatives to BE PHARMS drugs are available?
BE PHARMS has eleven approved drugs.
Drugs and US Patents for Be Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Be Pharms | SODIUM NITROPRUSSIDE | sodium nitroprusside | INJECTABLE;INJECTION | 214971-001 | Jul 12, 2021 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Be Pharms | ENOXAPARIN SODIUM (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 214646-006 | Jun 6, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Be Pharms | ENOXAPARIN SODIUM (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 214646-002 | Jun 6, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Be Pharms | NEOSTIGMINE METHYLSULFATE | neostigmine methylsulfate | SOLUTION;INTRAVENOUS | 212512-002 | May 13, 2019 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Be Pharms | PHENYLEPHRINE HYDROCHLORIDE | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 217521-003 | Jun 26, 2023 | AP2 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.